Core Viewpoint - The company, WuXi AppTec, has announced its 2025 mid-term profit distribution plan, which includes a cash dividend of RMB 3.5 per 10 shares, reflecting a strong financial performance in the first half of 2025 with a net profit of RMB 8.56 billion, a year-on-year increase of 101.9% [12][34][46]. Group 1: Company Overview - WuXi AppTec provides integrated, end-to-end new drug research and production services for the global pharmaceutical and life sciences industry [45]. - The company has maintained strong operational performance over the past 20 years, achieving a revenue of RMB 20.8 billion in the first half of 2025, a year-on-year increase of 20.6% [46]. Group 2: Financial Performance - For the first half of 2025, the company reported a net profit attributable to shareholders of RMB 8.56 billion, with a net profit growth of 101.9% year-on-year [12][34]. - The company’s revenue from continuing operations is expected to return to double-digit growth, with an adjusted growth rate of 13-17% for the year [46]. Group 3: Profit Distribution Plan - The board of directors approved a mid-term profit distribution plan, proposing a cash dividend of RMB 1,003,083,788.00 based on the adjusted total share capital [12][34]. - The dividend distribution is based on the total share capital after accounting for shares repurchased by the company [13][33]. Group 4: Corporate Governance and Management Changes - The company appointed Han Min as the new board secretary, following the resignation of the previous secretary, Zhang Yuanzhou [41][43]. - The board meeting held on July 28, 2025, was attended by all directors, ensuring compliance with legal and regulatory requirements [8][9]. Group 5: Strategic Initiatives - The company is focused on enhancing its core CRDMO business model to improve operational efficiency and service capabilities [46][49]. - WuXi AppTec is committed to sustainable development and has joined the UN Global Compact, aiming to integrate sustainability principles into its operations [52].